1. Home
  2. CSBR vs PROF Comparison

CSBR vs PROF Comparison

Compare CSBR & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • PROF
  • Stock Information
  • Founded
  • CSBR 1985
  • PROF N/A
  • Country
  • CSBR United States
  • PROF Canada
  • Employees
  • CSBR N/A
  • PROF N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • PROF Medical/Dental Instruments
  • Sector
  • CSBR Health Care
  • PROF Health Care
  • Exchange
  • CSBR Nasdaq
  • PROF Nasdaq
  • Market Cap
  • CSBR 123.2M
  • PROF 134.3M
  • IPO Year
  • CSBR 1986
  • PROF N/A
  • Fundamental
  • Price
  • CSBR $8.30
  • PROF $4.09
  • Analyst Decision
  • CSBR Strong Buy
  • PROF Strong Buy
  • Analyst Count
  • CSBR 1
  • PROF 1
  • Target Price
  • CSBR $12.00
  • PROF $11.00
  • AVG Volume (30 Days)
  • CSBR 30.4K
  • PROF 181.3K
  • Earning Date
  • CSBR 09-15-2025
  • PROF 11-06-2025
  • Dividend Yield
  • CSBR N/A
  • PROF N/A
  • EPS Growth
  • CSBR N/A
  • PROF N/A
  • EPS
  • CSBR 0.33
  • PROF N/A
  • Revenue
  • CSBR $56,944,000.00
  • PROF $11,840,000.00
  • Revenue This Year
  • CSBR $9.30
  • PROF $60.07
  • Revenue Next Year
  • CSBR $31.17
  • PROF $121.80
  • P/E Ratio
  • CSBR $24.12
  • PROF N/A
  • Revenue Growth
  • CSBR 13.54
  • PROF 59.81
  • 52 Week Low
  • CSBR $3.75
  • PROF $3.76
  • 52 Week High
  • CSBR $11.99
  • PROF $9.17
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 68.02
  • PROF 35.14
  • Support Level
  • CSBR $6.33
  • PROF $3.76
  • Resistance Level
  • CSBR $7.25
  • PROF $4.69
  • Average True Range (ATR)
  • CSBR 0.40
  • PROF 0.19
  • MACD
  • CSBR 0.09
  • PROF -0.00
  • Stochastic Oscillator
  • CSBR 81.74
  • PROF 33.67

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: